Chordia Therapeutics,Inc (190A) Other
Market cap
¥8.9B
P/E ratio
-4.5x
Chordia Therapeutics discovers and develops innovative small-molecule cancer drugs that target RNA regulatory stress in cancer cells for pharmaceutical partners.
| 2019/08 | 2020/08 | 2021/08 | 2022/08 | 2023/08 | 2024/08 | 2025/08 | |
| Return on Assets | - | - | - | - | 4.8 | -13.6 | -10.6 |
| Return on equity (%) | - | - | - | ||||
| Employees | 12 | 16 | 15 | 17 | 21 | 22 | 20 |